Group One Trading’s Microbot Medical MBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.8K Sell
24,000
-10,500
-30% -$21.4K ﹤0.01% 5439
2026
Q1
$83.1K Sell
34,500
-628,300
-95% -$1.4M ﹤0.01% 4892
2025
Q4
$1.33M Buy
662,800
+59,800
+10% +$142K ﹤0.01% 2647
2025
Q3
$1.84M Sell
603,000
-588,200
-49% -$1.83M ﹤0.01% 2405
2025
Q2
$3M Buy
1,191,200
+815,700
+217% +$1.95M 0.01% 1756
2025
Q1
$567K Buy
375,500
+374,000
+24,933% +$661K ﹤0.01% 2965
2024
Q4
$1.68K Buy
+1,500
New +$1.47K ﹤0.01% 6782
2024
Q3
Sell
-8,400
Closed -$8.57K 7046
2024
Q2
$8.57K Sell
8,400
-200
-2% -$206 ﹤0.01% 5711
2024
Q1
$10.6K Sell
8,600
-42,600
-83% -$54K ﹤0.01% 5835
2023
Q4
$84K Buy
51,200
+50,700
+10,140% +$67.5K ﹤0.01% 4607
2023
Q3
$695 Sell
500
-4,700
-90% -$10.2K ﹤0.01% 7279
2023
Q2
$14.1K Buy
+5,200
New +$10.4K ﹤0.01% 6199

Other funds holding MBOT

Group One Trading's MBOT Position: Q2 2026 in Review

Group One Trading increased its Microbot Medical (MBOT) stake by 129% in Q2 2026, buying an estimated $122K and bringing the position to 106,429 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #4254.

Group One Trading first reported a position in MBOT in Q2 2023 and has held it in 8 quarters since. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Group One Trading held 106,429 shares of Microbot Medical worth $208K as of Q2 2026.
  • Group One Trading bought 59,866 Microbot Medical shares in Q2 2026, an estimated $122K.
  • Microbot Medical made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #4254 holding.
  • Group One Trading first reported a position in Microbot Medical in Q2 2023 and has held it in 8 quarters since.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.